Suppr超能文献

头颈部软组织肉瘤患者的新型位置-分级-淋巴结-转移分期系统

Novel Location-Grading-Node-Metastasis Staging System in Patients With Head and Neck Soft Tissue Sarcoma.

作者信息

Du Dingfu, Wu Shaojun, Wang Zilu, Guan Yuanxiang, Jiang Ke, Xu Bushu, Liang Yao

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

出版信息

J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251333359. doi: 10.1177/19160216251333359. Epub 2025 May 1.

Abstract

ImportanceUnlike other head and neck cancers, head and neck soft tissue sarcoma (HN-STS) is staged similarly to sarcomas in the trunk and extremities. The current American Joint Committee on Cancer (AJCC) staging system has limitations that hinder accurate prognosis prediction for HN-STS.ObjectiveWe aimed to develop a novel location-grading-node-metastasis (LGNM) staging system based on the primary tumor location to more accurately stratify prognosis for HN-STS.DesignA retrospective case series from 1990 to 2021.Setting/ParticipantsThis study included 471 patients diagnosed with HN-STS at Sun Yat-sen University Cancer Center between 1990 and 2021.Main outcome measuresIn the primary analysis, we obtained the overall survival (OS) rate. Secondary measures included area under the receiver operating characteristic curve, Harrell's , Somers' , Gönen and Heller's , O'Quigley's ρ2, Royston's , the Bayesian information criterion for concordance, and variation in patient outcomes.ResultsThe eighth edition of AJCC T classification for tumor size inadequately conveys prognosis information. In contrast, the primary tumor location and local invasion are prognostic factors for HN-STS and categorized into 4 stages: L1 (low risk: scalp, face, supraclavicular, ear), L2 (intermediate risk: neck, paravertebral, pharynx, tonsil, eye, orbit), L3 (high risk: cavity, lip, palate, buccal mucosa, salivary gland, maxilla, mandible), and L4 (any location with local invasion). The new LGNM staging system effectively distributed patients into stages I to IV, with statistically-significant survival differences among these stages. Five-year OS rates were 96.9% for stage I, 78.4% for stage II, 37.1% for stage III, and 7.1% for stage IV ( < .001). Additionally, the LGNM staging system demonstrated superior predictive ability and concordance compared with the seventh and eighth editions of AJCC staging systems.Conclusions/RelevanceThe LGNM staging system shows better homogeneity and discriminatory power than the AJCC system, improving risk stratification and prognosis prediction in HN-STS.

摘要

重要性

与其他头颈癌不同,头颈部软组织肉瘤(HN-STS)的分期与躯干和四肢的肉瘤相似。当前的美国癌症联合委员会(AJCC)分期系统存在局限性,阻碍了对HN-STS准确的预后预测。

目的

我们旨在基于原发肿瘤位置开发一种新的位置-分级-淋巴结-转移(LGNM)分期系统,以更准确地对HN-STS的预后进行分层。

设计

1990年至2021年的回顾性病例系列研究。

设置/参与者

本研究纳入了1990年至2021年间在中山大学肿瘤防治中心诊断为HN-STS的471例患者。

主要结局指标

在初步分析中,我们获得了总生存率(OS)。次要指标包括受试者工作特征曲线下面积、Harrell's 、Somers' 、Gönen和Heller's 、O'Quigley's ρ2、Royston's 、一致性的贝叶斯信息准则以及患者结局的差异。

结果

AJCC肿瘤大小的第八版T分类未能充分传达预后信息。相比之下,原发肿瘤位置和局部侵犯是HN-STS的预后因素,分为4期:L1(低风险:头皮、面部、锁骨上、耳部),L2(中度风险:颈部、椎旁、咽部、扁桃体、眼部、眼眶),L3(高风险:口腔、唇部、腭部、颊黏膜、唾液腺、上颌骨、下颌骨),以及L4(任何有局部侵犯的位置)。新的LGNM分期系统有效地将患者分为I至IV期,这些分期之间的生存差异具有统计学意义。I期的5年OS率为96.9%,II期为78.4%,III期为37.1%,IV期为7.1%(  < .001)。此外,与AJCC分期系统的第七版和第八版相比,LGNM分期系统显示出更好的预测能力和一致性。

结论/相关性

LGNM分期系统比AJCC系统显示出更好的同质性和区分能力,改善了HN-STS的风险分层和预后预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a209/12049617/59edb2844154/10.1177_19160216251333359-img2.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验